Consistently, flow cytometry analysis showed that restoration of Rpl29 rescued the Prmt1 deletion‐mediated reductions of the leukemia burden and proportions of LSPCs in secondary CML mice (Figure 6F–M). The gene discussed is RPL29; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.